12:00 AM
Feb 21, 2011
 |  BC Week In Review  |  Company News  |  Deals

Gruenenthal, Xention deal

Xention partnered with the Gruenenthal to develop ion channel based drugs to treat chronic pain. Xention will use its drug discovery platform to...

Read the full 95 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >